Loading clinical trials...
Loading clinical trials...
This study assesses the feasibility of a full course of Low Pulse Amplitude-Seizure Therapy (LAP-ST) (primary outcome).
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Behman Hospital
NCT06740383 · Schizophrenia Spectrum and Other Psychotic Disorders, Schizophrenia, and more
NCT06854367 · Late Life Depression (LLD), Depression - Major Depressive Disorder, and more
NCT06568081 · Schizophrenia Spectrum and Other Psychotic Disorders, Affective Psychoses
NCT07211750 · Multimorbidity, Older Adults (65 Years and Older), and more
NCT05658796 · Mood Disorders, Anxiety, and more
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions